98 related articles for article (PubMed ID: 10429649)
21. TAp63gamma (p51A) and dNp63alpha (p73L), two major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth factor (VEGF) gene expression.
Senoo M; Matsumura Y; Habu S
Oncogene; 2002 Apr; 21(16):2455-65. PubMed ID: 11971180
[TBL] [Abstract][Full Text] [Related]
22. Definition of a p53 transactivation function-deficient mutant and characterization of two independent p53 transactivation subdomains.
Venot C; Maratrat M; Sierra V; Conseiller E; Debussche L
Oncogene; 1999 Apr; 18(14):2405-10. PubMed ID: 10327062
[TBL] [Abstract][Full Text] [Related]
23. Design of artificial transcription factors to selectively regulate the pro-apoptotic bax gene.
Falke D; Fisher M; Ye D; Juliano RL
Nucleic Acids Res; 2003 Feb; 31(3):e10. PubMed ID: 12560513
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
Park US; Park SK; Lee YI; Park JG; Lee YI
Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
[TBL] [Abstract][Full Text] [Related]
25. The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21(BAX) expression.
Shu HK; Kim MM; Chen P; Furman F; Julin CM; Israel MA
Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14453-8. PubMed ID: 9826721
[TBL] [Abstract][Full Text] [Related]
26. RB18A, whose gene is localized on chromosome 17q12-q21.1, regulates in vivo p53 transactivating activity.
Frade R; Balbo M; Barel M
Cancer Res; 2000 Dec; 60(23):6585-9. PubMed ID: 11118038
[TBL] [Abstract][Full Text] [Related]
27. p53 family genes: structural comparison, expression and mutation.
Ikawa S; Nakagawara A; Ikawa Y
Cell Death Differ; 1999 Dec; 6(12):1154-61. PubMed ID: 10637430
[TBL] [Abstract][Full Text] [Related]
28. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
29. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.
Hemmati PG; Gillissen B; von Haefen C; Wendt J; Stärck L; Güner D; Dörken B; Daniel PT
Oncogene; 2002 May; 21(20):3149-61. PubMed ID: 12082630
[TBL] [Abstract][Full Text] [Related]
30. Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells.
Gottlieb E; Lindner S; Oren M
Cell Growth Differ; 1996 Mar; 7(3):301-10. PubMed ID: 8838860
[TBL] [Abstract][Full Text] [Related]
31. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
Frank DK; Liu TJ; Frederick MJ; Clayman GL
Clin Cancer Res; 1998 Sep; 4(9):2265-72. PubMed ID: 9748148
[TBL] [Abstract][Full Text] [Related]
32. Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeast.
Flaman JM; Robert V; Lenglet S; Moreau V; Iggo R; Frebourg T
Oncogene; 1998 Mar; 16(10):1369-72. PubMed ID: 9546439
[TBL] [Abstract][Full Text] [Related]
33. The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression.
Venot C; Maratrat M; Dureuil C; Conseiller E; Bracco L; Debussche L
EMBO J; 1998 Aug; 17(16):4668-79. PubMed ID: 9707426
[TBL] [Abstract][Full Text] [Related]
34. Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas.
Kanavaros P; Stefanaki K; Vlachonikolis J; Eliopoulos G; Kakolyris S; Rontogianni D; Gorgoulis V; Georgoulias V
Histol Histopathol; 2000 Apr; 15(2):445-53. PubMed ID: 10809363
[TBL] [Abstract][Full Text] [Related]
35. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
[TBL] [Abstract][Full Text] [Related]
36. One mechanism for cell type-specific regulation of the bax promoter by the tumor suppressor p53 is dictated by the p53 response element.
Thornborrow EC; Manfredi JJ
J Biol Chem; 1999 Nov; 274(47):33747-56. PubMed ID: 10559267
[TBL] [Abstract][Full Text] [Related]
37. Effects of p51/p63 missense mutations on transcriptional activities of p53 downstream gene promoters.
Kato S; Shimada A; Osada M; Ikawa S; Obinata M; Nakagawara A; Kanamaru R; Ishioka C
Cancer Res; 1999 Dec; 59(23):5908-11. PubMed ID: 10606233
[TBL] [Abstract][Full Text] [Related]
38. Regulation of p53 target gene expression by cisplatin-induced extracellular signal-regulated kinase.
DeHaan RD; Yazlovitskaya EM; Persons DL
Cancer Chemother Pharmacol; 2001 Nov; 48(5):383-8. PubMed ID: 11761456
[TBL] [Abstract][Full Text] [Related]
39. K-ras modulates the cell cycle via both positive and negative regulatory pathways.
Fan J; Bertino JR
Oncogene; 1997 May; 14(21):2595-607. PubMed ID: 9191059
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of p21 by p53 and Rb in cellular response to oxidative stress.
Yin Y; Solomon G; Deng C; Barrett JC
Mol Carcinog; 1999 Jan; 24(1):15-24. PubMed ID: 10029406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
